These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18401336)

  • 1. Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis.
    Swaminathan S; High WA; Ranville J; Horn TD; Hiatt K; Thomas M; Brown HH; Shah SV
    Kidney Int; 2008 Jun; 73(12):1413-8. PubMed ID: 18401336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue gadolinium deposition and fibrosis mimicking nephrogenic systemic fibrosis (NSF)-subclinical nephrogenic systemic fibrosis?
    Boyd AS; Sanyal S; Abraham JL
    J Am Acad Dermatol; 2010 Feb; 62(2):337-42. PubMed ID: 19939504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
    Kalb RE; Helm TN; Sperry H; Thakral C; Abraham JL; Kanal E
    Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrogenic systemic fibrosis: a report of 29 cases.
    Shabana WM; Cohan RH; Ellis JH; Hussain HK; Francis IR; Su LD; Mukherji SK; Swartz RD
    AJR Am J Roentgenol; 2008 Mar; 190(3):736-41. PubMed ID: 18287446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nephrogenic systemic fibrosis and gadolinium-based contrast media].
    Andréjak M; Thuillier D; Lok C; Gras-Champel V
    Therapie; 2007; 62(2):169-72. PubMed ID: 17582319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.
    Collidge TA; Thomson PC; Mark PB; Traynor JP; Jardine AG; Morris ST; Simpson K; Roditi GH
    Radiology; 2007 Oct; 245(1):168-75. PubMed ID: 17704357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephrogenic systemic fibrosis].
    Cavallini L; Abaterusso C; Bedogna V; Pertica N; Loschiavo C; Lupo A
    G Ital Nefrol; 2008; 25(1):14-20. PubMed ID: 18264914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nephrogenic systemic fibrosis].
    Breitschaft A; Stahlmann R
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of gadolinium in nephrogenic systemic fibrosis: re-examination of a reported cohort with analysis of clinical factors.
    Khurana A; Greene JF; High WA
    J Am Acad Dermatol; 2008 Aug; 59(2):218-24. PubMed ID: 18538448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent decrement of dermal gadolinium deposits and significant improvement of skin symptoms in a patient with nephrogenic systemic fibrosis after temporary renal failure.
    Schäd SG; Heitland P; Kühn-Velten WN; Gross GE; Jonas L
    J Cutan Pathol; 2013 Nov; 40(11):935-44. PubMed ID: 24102613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD; Bernheisel CR
    Am Fam Physician; 2009 Oct; 80(7):711-4. PubMed ID: 19817341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
    Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
    Todd DJ; Kagan A; Chibnik LB; Kay J
    Arthritis Rheum; 2007 Oct; 56(10):3433-41. PubMed ID: 17907148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
    Kitajima K; Maeda T; Watanabe S; Ueno Y; Sugimura K
    Int J Urol; 2012 Sep; 19(9):806-11. PubMed ID: 22571387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gadolinium chelate-associated nephrogenic systemic fibrosis.
    Kei PL; Chan LP
    Singapore Med J; 2008 Mar; 49(3):181-5. PubMed ID: 18362996
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
    Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
    Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metal deposition in calcific uremic arteriolopathy.
    Amuluru L; High W; Hiatt KM; Ranville J; Shah SV; Malik B; Swaminathan S
    J Am Acad Dermatol; 2009 Jul; 61(1):73-9. PubMed ID: 19406504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium and nephrogenic systemic fibrosis.
    Grobner T; Prischl FC
    Kidney Int; 2007 Aug; 72(3):260-4. PubMed ID: 17507905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephrogenic systemic fibrosis].
    Pintér I; Vágási K; Wittmann I; Nagy J
    Orv Hetil; 2007 Sep; 148(38):1801-4. PubMed ID: 17872335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiorgan gadolinium (Gd) deposition and fibrosis in a patient with nephrogenic systemic fibrosis--an autopsy-based review.
    Sanyal S; Marckmann P; Scherer S; Abraham JL
    Nephrol Dial Transplant; 2011 Nov; 26(11):3616-26. PubMed ID: 21441397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.